Table 2.

Toxicity of preoperative capecitabine therapy.

Toxicity	Grade 1–2, n (%)	Grade 3, n (%)	Grades 1–3,%
Palmar-plantar erythrodysesthesia	19 (79.2%)	1 (4.2%)	83.3%
Diarrhea	15 (62.5%)	1 (4.2%)	66.7%
Anemia	9 (37.5%)	0 (0%)	37.5%
Nausea	9 (37.5%)	0 (0%)	37.5%
Fatigue	8 (33.3%)	0 (0%)	33.3%
Mucositis	4 (16.7%)	1 (4.2%)	20.8%
AST/ALT	4 (16.7%)	0 (0%)	16.7%
Abdominal pain	4 (16.7%)	0 (0%)	16.7%
Anorexia	3 (12.5%)	0 (0%)	12.5%
Elevated bilirubin	3 (12.5%)	0 (0%)	12.5%
Hyperglycemia	3 (12.5%)	0 (0%)	12.5%
Insomnia	3 (12.5%)	0 (0%)	12.5%
Leukopenia	3(12.5%)	0 (0%)	12.5%
Rash	3 (12.5%)	0 (0%)	12.5%
Hypokalemia	0 (0%)	1 (4.2%)	4.2%